Cargando…

Mutational processes in cancer preferentially affect binding of particular transcription factors

Protein binding microarrays provide comprehensive information about the DNA binding specificities of transcription factors (TFs), and can be used to quantitatively predict the effects of DNA sequence variation on TF binding. There has also been substantial progress in dissecting the patterns of muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mo, Boot, Arnoud, Ng, Alvin W. T., Gordân, Raluca, Rozen, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870974/
https://www.ncbi.nlm.nih.gov/pubmed/33558557
http://dx.doi.org/10.1038/s41598-021-82910-0
_version_ 1783648919571398656
author Liu, Mo
Boot, Arnoud
Ng, Alvin W. T.
Gordân, Raluca
Rozen, Steven G.
author_facet Liu, Mo
Boot, Arnoud
Ng, Alvin W. T.
Gordân, Raluca
Rozen, Steven G.
author_sort Liu, Mo
collection PubMed
description Protein binding microarrays provide comprehensive information about the DNA binding specificities of transcription factors (TFs), and can be used to quantitatively predict the effects of DNA sequence variation on TF binding. There has also been substantial progress in dissecting the patterns of mutations, i.e., the "mutational signatures", generated by different mutational processes. By combining these two layers of information we can investigate whether certain mutational processes tend to preferentially affect binding of particular classes of TFs. Such preferential alterations of binding might predispose to particular oncogenic pathways. We developed and implemented a method, termed "Signature-QBiC", that integrates protein binding microarray data with the signatures of mutational processes, with the aim of predicting which TFs’ binding profiles are preferentially perturbed by particular mutational processes. We used Signature-QBiC to predict the effects of 47 signatures of mutational processes on 582 human TFs. Pathway analysis showed that binding of TFs involved in NOTCH1 signaling is strongly affected by the signatures of several mutational processes, including exposure to ultraviolet radiation. Additionally, toll-like-receptor signaling pathways are also vulnerable to disruption by this exposure. This study provides a novel overview of the effects of mutational processes on TF binding and the potential of these processes to activate oncogenic pathways through mutating TF binding sites.
format Online
Article
Text
id pubmed-7870974
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78709742021-02-10 Mutational processes in cancer preferentially affect binding of particular transcription factors Liu, Mo Boot, Arnoud Ng, Alvin W. T. Gordân, Raluca Rozen, Steven G. Sci Rep Article Protein binding microarrays provide comprehensive information about the DNA binding specificities of transcription factors (TFs), and can be used to quantitatively predict the effects of DNA sequence variation on TF binding. There has also been substantial progress in dissecting the patterns of mutations, i.e., the "mutational signatures", generated by different mutational processes. By combining these two layers of information we can investigate whether certain mutational processes tend to preferentially affect binding of particular classes of TFs. Such preferential alterations of binding might predispose to particular oncogenic pathways. We developed and implemented a method, termed "Signature-QBiC", that integrates protein binding microarray data with the signatures of mutational processes, with the aim of predicting which TFs’ binding profiles are preferentially perturbed by particular mutational processes. We used Signature-QBiC to predict the effects of 47 signatures of mutational processes on 582 human TFs. Pathway analysis showed that binding of TFs involved in NOTCH1 signaling is strongly affected by the signatures of several mutational processes, including exposure to ultraviolet radiation. Additionally, toll-like-receptor signaling pathways are also vulnerable to disruption by this exposure. This study provides a novel overview of the effects of mutational processes on TF binding and the potential of these processes to activate oncogenic pathways through mutating TF binding sites. Nature Publishing Group UK 2021-02-08 /pmc/articles/PMC7870974/ /pubmed/33558557 http://dx.doi.org/10.1038/s41598-021-82910-0 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Liu, Mo
Boot, Arnoud
Ng, Alvin W. T.
Gordân, Raluca
Rozen, Steven G.
Mutational processes in cancer preferentially affect binding of particular transcription factors
title Mutational processes in cancer preferentially affect binding of particular transcription factors
title_full Mutational processes in cancer preferentially affect binding of particular transcription factors
title_fullStr Mutational processes in cancer preferentially affect binding of particular transcription factors
title_full_unstemmed Mutational processes in cancer preferentially affect binding of particular transcription factors
title_short Mutational processes in cancer preferentially affect binding of particular transcription factors
title_sort mutational processes in cancer preferentially affect binding of particular transcription factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870974/
https://www.ncbi.nlm.nih.gov/pubmed/33558557
http://dx.doi.org/10.1038/s41598-021-82910-0
work_keys_str_mv AT liumo mutationalprocessesincancerpreferentiallyaffectbindingofparticulartranscriptionfactors
AT bootarnoud mutationalprocessesincancerpreferentiallyaffectbindingofparticulartranscriptionfactors
AT ngalvinwt mutationalprocessesincancerpreferentiallyaffectbindingofparticulartranscriptionfactors
AT gordanraluca mutationalprocessesincancerpreferentiallyaffectbindingofparticulartranscriptionfactors
AT rozensteveng mutationalprocessesincancerpreferentiallyaffectbindingofparticulartranscriptionfactors